# Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.

> **NCT05135039** · NA · UNKNOWN · sponsor: **xiaolong zhao** · enrollment: 218 (estimated)

## Conditions studied

- PreDiabetes
- Hiv

## Interventions

- **DRUG:** Canagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05135039
- **Lead sponsor:** xiaolong zhao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135039, "Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT05135039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*